Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pilot Of New US Evaluation System Will Include At Least Two Devices

Executive Summary

New details about the planned pilot launch of the National Evaluation System for health Technology were included in US FDA's recently posted user-fee reauthorization commitment letter. At least one PMA and one 510(k) product type must be piloted on the real-world evidence system. Device center director Jeff Shuren continued to tout the program at this year's AdvaMed conference.

Advertisement

Related Content

Applying Real-World Device Data: US FDA Finalizes Its Thoughts
MDUFA IV (And More) Is Law: Trump Signs A Health-Care Bill
NEST Executive Director: A One Woman Army
Shuren At FDLI: Least-Burdensome, Real-World Evidence Efforts Picking Up
A New NEST: MDIC Leaders Discuss Relocation, National Evaluation System And More
Gottlieb Wants Timely Approval Of User Fee Bill, Balanced LDT Plan
MDIC Snags $3m For FDA Real-World Evidence Coordinating Center
$30m In Device User Fees Will Go To Real-World Evidence Evaluation System
Industry Urges Caution In Response To Growing Push For 'Real-World' Device Evaluation System
Negotiating Prices For Real-World Data Can Lower FDA Submission Costs, Shuren Says

Topics

Advertisement
UsernamePublicRestriction

Register

MT104032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel